Treatment of Parkinson's disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa

Med Ann Dist Columbia. 1974 Dec;43(12):587-91.

J Fermaglich

PMID: 4532167

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-B0311

Carbidopa

≥98.0%, Decarboxylase Inhibitor

Aryl Hydrocarbon Receptor

Neurological Disease; Cancer
HY-B0311A

Carbidopa monohydrate

≥98.0%, Aryl Hydrocarbon Receptor Modulator

Aryl Hydrocarbon Receptor

Neurological Disease; Cancer
HY-B0311AS

Carbidopa-d₃ monohydrate

≥98.0%, Stable Isotope

Aryl Hydrocarbon Receptor

Neurological Disease; Cancer
HY-B0311S1

Carbidopa-d₃-1

Stable Isotope

Aryl Hydrocarbon Receptor; Isotope-Labeled Compounds

Neurological Disease
HY-B0311D

Carbidopa hydrochloride

Decarboxylase Inhibitor

Others; Aryl Hydrocarbon Receptor

Cancer

MedChemExpress Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator

Subscribe to our E-newsletter

Name
Email *

	Sorry, but the email address you supplied was invalid.

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2024 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us